Literature DB >> 7354244

Antibiotic uptake by alveolar macrophages.

J D Johnson, W L Hand, J B Francis, N King-Thompson, R W Corwin.   

Abstract

Optimal therapy of infections caused by bacteria able to survive within phagocytes requires the use of antibiotics which inactivate these intracellular organisms. To define characteristics that determine entry of antimicrobial agents into phagocytes, we studied the uptake of 14 radiolabeled antibiotics by rabbit AM. Cell-antibiotic mixtures were incubated for 2 hr, and at intervals antibiotic uptake was determined by velocity-gradient centrifugation (separation of cells from extracellular antibiotic). Many drugs failed to penetrate AM readily. Cellular concentrations of penicillin G and three cephalosporin antibiotics were much lower than extracellular levels (C/E = less than 0.1 to 0.4). Gentamicin, isoniazid, and tetracycline attained C/E values of 0.5 to 0.8. The more lipid-soluble antibiotics, refampin, lincomycin, and chloramphenicol, were concentrated approximately twofold (C/E = 2) in AM. Ethambutol (C/E = 7) and two erythromycin preparations (C/E = greater than 20) were markedly accumulated by macrophages. In comparison with other antibiotics tested, the uptake of clindamycin was both massive and rapid (C/E = 50 by 30 min). Ethambutol, erythromycin and clindamycin uptakes by AM are dependent upon oxidative metabolic processes. Detailed characterization of clindamycin uptake confirmed that the drug is accumulated by an active transport system. These findings, in association with studies of antibiotic-mediated influence on phagocytes, should provide information useful in establishing guidelines for optimal antibiotic usage.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7354244

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  84 in total

Review 1.  Use of aminoglycosides in treatment of infections due to intracellular bacteria.

Authors:  M Maurin; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

2.  Survival of Enterococcus faecalis in mouse peritoneal macrophages.

Authors:  C R Gentry-Weeks; R Karkhoff-Schweizer; A Pikis; M Estay; J M Keith
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

3.  Growth of Brucella abortus in macrophages from resistant and susceptible mouse strains.

Authors:  J Sathiyaseelan; X Jiang; C L Baldwin
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

Review 4.  Pulmonary disposition of antimicrobial agents: methodological considerations.

Authors:  D R Baldwin; D Honeybourne; R Wise
Journal:  Antimicrob Agents Chemother       Date:  1992-06       Impact factor: 5.191

Review 5.  Pulmonary disposition of antimicrobial agents: in vivo observations and clinical relevance.

Authors:  D R Baldwin; D Honeybourne; R Wise
Journal:  Antimicrob Agents Chemother       Date:  1992-06       Impact factor: 5.191

Review 6.  Treatment of pulmonary disease caused by opportunist mycobacteria.

Authors:  J Banks
Journal:  Thorax       Date:  1989-06       Impact factor: 9.139

Review 7.  Genetics and pulmonary medicine. 5. Genetics of drug resistant tuberculosis.

Authors:  A Telenti
Journal:  Thorax       Date:  1998-09       Impact factor: 9.139

8.  Pentoxifylline modulation of plasma membrane functions in human polymorphonuclear leukocytes.

Authors:  W L Hand; M L Butera; N L King-Thompson; D L Hand
Journal:  Infect Immun       Date:  1989-11       Impact factor: 3.441

9.  Effect of subinhibitory concentrations of josamycin on the expression of M protein by group A streptococci.

Authors:  C Lam; E Basalka
Journal:  Eur J Clin Microbiol       Date:  1985-06       Impact factor: 3.267

10.  Factors influencing the accumulation of ciprofloxacin in Pseudomonas aeruginosa.

Authors:  R A Celesk; N J Robillard
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.